Skip to main
GEHC

GEHC Stock Forecast & Price Target

GEHC Analyst Ratings

Based on 14 analyst ratings
Buy
Strong Buy 21%
Buy 29%
Hold 43%
Sell 0%
Strong Sell 7%

Bulls say

GE HealthCare Techs is expected to show 3.4% organic revenue growth in FY26, driven by strong demand for imaging and ultrasound equipment, recurring revenue streams such as servicing and pharmaceutical diagnostics, and continued international expansion. The company has a solid financial outlook with an estimated EPS of $4.84 and an EBIT margin of 15.4% - 15.7%. Additionally, GE HealthCare's recent M&A activity and new product launches are expected to drive future revenue growth.

Bears say

GE HealthCare Techs is a leading medical technology firm, with a diverse geographical presence and strong recurring revenue. However, the company has faced challenges from trade wars and inflationary dynamics, leading to underperformance post-spin. While there are opportunities for growth and margin improvements, ongoing macroeconomic challenges and competition in key markets could impact future performance. Investors should also keep an eye on potential disruptions to manufacturing and supply chain.

GEHC has been analyzed by 14 analysts, with a consensus rating of Buy. 21% of analysts recommend a Strong Buy, 29% recommend Buy, 43% suggest Holding, 0% advise Selling, and 7% predict a Strong Sell.

This aggregate rating is based on analysts' research of GE HealthCare Technologies Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About GE HealthCare Technologies Inc (GEHC) Forecast

Analysts have given GEHC a Buy based on their latest research and market trends.

According to 14 analysts, GEHC has a Buy consensus rating as of May 5, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $81.64, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $81.64, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

GE HealthCare Technologies Inc (GEHC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.